Abstract
Introduction
Adhesive capsulitis (frozen shoulder) is a relatively prevalent disease of shoulder and affects soft tissue of glenohumeral joint. Signs include painful restricted motion and disability of the patient in daily activities. Calcitonin is a thyroid hormone, and its effectiveness has been demonstrated in painful conditions. The presents study aims to evaluate the effect of calcitonin in treating shoulder adhesive capsulitis.
Method
This double-blinded randomized clinical trial was conducted on 64 patients suffering from shoulder adhesive capsulitis. The intervention and control groups were given intranasal calcitonin and placebo for 6 weeks, respectively. For both groups, physiotherapy and non-steroidal anti-inflammatory drugs were administered correspondingly. The patients were evaluated pre- and post-treatment for shoulder pain and shoulder range of motion (ROM). Shoulder functional outcome (secondary outcome) was evaluated using Disability of Arm, Shoulder, and Hand, Shoulder Pain and Disability Index, and Health Assessment Questionnaire disability criteria.
Results
The mean age of patients in calcitonin and control group was 52.4 ± 4.6 and 53.2 ± 4.9, respectively. Demographic characteristics and pre-treatment scores were similar in both groups (all P > 0.05). In post-treatment follow-up, shoulder pain, ROM, and the patients’ functional scores were significantly improved in both groups (P < 0.001); however, the improvement in calcitonin group was more effective than that of placebo group.
Conclusion
Intranasal calcitonin spray could be an additional safe alternative in shoulder adhesive capsulitis with regard to the efficiency in alleviating pain and improving functional outcome.
Level of evidence
II.
Similar content being viewed by others
References
Brue S, Valentin A, Forssblad M, Werner S, Mikkelsen C, Cerulli G (2007) Idiopathic adhesive capsulitis of the shoulder: a review. Knee Surg Sports Traumatol Arthrosc 15(8):1048–1054. doi:10.1007/s00167-007-0291-2
Neviaser AS, Neviaser RJ (2011) Adhesive capsulitis of the shoulder. J Am Acad Orthop Surg 19(9):536–542
Tighe CB, Oakley WS Jr (2008) The prevalence of a diabetic condition and adhesive capsulitis of the shoulder. South Med J 101(6):591–595. doi:10.1097/SMJ.0b013e3181705d39
D’Orsi GM, Via AG, Frizziero A, Oliva F (2012) Treatment of adhesive capsulitis: a review. Muscles Ligaments Tendons J 2(2):70–78
Appelboom T (2002) Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions. Bone 30(5 Suppl):84S–86S. doi:10.1016/S8756-3282(02)00702-0
Lorbach O, Anagnostakos K, Scherf C, Seil R, Kohn D, Pape D (2010) Nonoperative management of adhesive capsulitis of the shoulder: oral cortisone application versus intra-articular cortisone injections. J Shoulder Elbow Surg 19(2):172–179. doi:10.1016/j.jse.2009.06.013
Buchbinder R, Hoving JL, Green S, Hall S, Forbes A, Nash P (2004) Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial. Ann Rheum Dis 63(11):1460–1469. doi:10.1136/ard.2003.018218
Sahin F, Yilmaz F, Kotevoglu N, Kuran B (2006) Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clin Rheumatol 25(2):143–148. doi:10.1007/s10067-005-1153-2
Waldburger M, Meier JL, Gobelet C (1992) The frozen shoulder: diagnosis and treatment. Prospective study of 50 cases of adhesive capsulitis. Clin Rheumatol 11(3):364–368
Reginster JY, Franchimont P (1985) Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clin Exp Rheumatol 3(2):155–157
Wimalawansa SJ (1993) Long- and short-term side effects and safety of calcitonin in man: a prospective study. Calcif Tissue Int 52(2):90–93
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects (2008) World Medical Association. http://www.wma.net/en/30publications/10policies/b3/. Accessed 15 Apr 2013
Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 1(2):100–107
Neviaser RJ, Neviaser TJ (1987) The frozen shoulder. Diagnosis and management. Clin Orthop Relat Res 223:59–64
Ogilvie-Harris DJ, Biggs DJ, Fitsialos DP, MacKay M (1995) The resistant frozen shoulder. Manipulation versus arthroscopic release. Clin Orthop Relat Res 319:238–248
Cinar M, Akpinar S, Derincek A, Circi E, Uysal M (2010) Comparison of arthroscopic capsular release in diabetic and idiopathic frozen shoulder patients. Arch Orthop Trauma Surg 130(3):401–406. doi:10.1007/s00402-009-0900-2
Omari A, Bunker TD (2001) Open surgical release for frozen shoulder: surgical findings and results of the release. J Shoulder Elbow Surg 10(4):353–357. doi:10.1067/mse.2001.115986
Ewald A (2011) Adhesive capsulitis: a review. Am Fam Physician 83(4):417–422
Azria M (2002) Possible mechanisms of the analgesic action of calcitonin. Bone 30(5 Suppl):80s–83s
Braga PC (1994) Calcitonin and its antinociceptive activity: animal and human investigations 1975–1992. Agents Actions 41(3–4):121–131
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Ethical approval
Tabriz University of Medical Sciences Ethics Committee approved the study, and it was registered on the Iranian Registry of Clinical Trials (IRCT No.: IRCT2013080414271n1).
Rights and permissions
About this article
Cite this article
Rouhani, A., Mardani-Kivi, M., Bazavar, M. et al. Calcitonin effects on shoulder adhesive capsulitis. Eur J Orthop Surg Traumatol 26, 575–580 (2016). https://doi.org/10.1007/s00590-016-1816-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-016-1816-5